Northside Hospital Cancer Institute and Georgia Cancer Specialists offer Phase I through IV clinical research trials. Our Phase I program includes novel “first in human” trials. We offer community-based medical oncology and hematology services and we also provide a full range of support services for patients in Georgia, including imaging services, retail pharmacy, nutritional counseling, wellness counseling, and home health coordination.
Six dedicated research clinics are located in geographically distinct practice areas. Our clinical trials are conducted at our Kennestone (Marietta), Northside (North Atlanta), Stemmer (Decatur), Macon, Athens, and Cumming (Forsyth) offices. Because of our strong commitment to research, we are affiliated with the University of Alabama-Birmingham Comprehensive Cancer Center (UABCCC), making it possible to bring leading-edge cancer care to our patients.
Dr. Mansoor Saleh is the director of clinical research at GCS and is also a professor of medicine at UABCCC. He has overseen the research program at GCS for more than a decade and monitors trials from our Northside location. Currently, fourteen other sub-investigators oversee the treatment of all GCS patients on clinical trials. Dr. Aaron Alizadeh, MD, Dr. Simbo Aduloju, MD, and Dr. Jayanthi Srinivasiah (Dr. Jay), MD monitor trials from our Stemmer location; Dr. Cheryl Jones, MD, Dr. , and Dr. Premila Malhotra, MD monitor trials from our Macon-Coliseum location; Dr. Rodolfo Bordoni, MD and Dr. Gena Volas-Redd, MD monitor trials from our Kennestone location; Richard Loyd, DO, Dr. Ranjana Bhargava, MD, and Dr. Priya Rudolph, M.D., PhD monitor trial from our Athens location; and Dr. Jorge Leguizamo, MD and Dr. Nishan Fernando, MD monitor trials from our Cumming location. The research team is comprised of physicians and specialized clinical staff trained in research design, data collection, and analysis.